Insulin resistance and β‐cell dysfunction in normoglycaemic European women with a history of gestational diabetes
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Summary: objective Women with previous gestational diabetes (GDM) are at increased risk of subsequent type 2 diabetes. To characterize early metabolic abnormalities associated with this increased risk, we studied normoglycaemic women with a history of GDM. patients and measurements We performed an insulin‐modified, frequently sampled intravenous glucose tolerance test (FSIVGTT) in 34 normoglycaemic European women with previous GDM and 44 European control women, deriving measures of insulin sensitivity, glucose effectiveness, glucose disappearance rate and acute insulin response to glucose. results Post‐GDM women were more obese than controls [body mass index (BMI), geometric mean (95% confidence interval); 25·3 kg/m 2 (23·8–27·1 kg/m 2) vs. 23·1 kg/m 2 (21·9–24·3 kg/m 2), P = 0·03]. Evidence of insulin resistance was provided by their lower insulin sensitivity as measured by FSIVGTT [0·6 × 10−4/min/pmol/l (0·3–1·2 × 10−4/min/pmol/l) vs. 1·5 × 10−4/min/pmol/l (1·2–1·8 × 10−4/min/pmol/l), P = 0·01] and by homeostatic model assessment [72% (49–107%) vs. 153% (113–206%), P = 0·004]; and by their higher fasting triglycerides [1·0 mmol/l (0·7–1·5 mmol/l) vs. 0·7 mmol/l (0·6–0·8 mmol/l), P = 0·001]. Though there was no difference between groups in fasting NEFA levels, acute NEFA suppression was diminished in the post‐GDM group (P = 0·01). Concomitant β‐cell dysfunction in the post‐GDM women was revealed by their lower disposition index [0·05/min (0·02–0·10/min) vs. 0·11/min (0·09–0·14/min), P = 0·02] compared to controls. The differences in insulin sensitivity, but not those of β‐cell function, were partly, though not completely, attributable to differences in regional and total adiposity. conclusions European normoglycaemic women with previous GDM display both glucoregulatory and antilipolytic insulin resistance, reduced β‐cell function and dyslipidaemia. These metabolic abnormalities are likely to contribute to their increased risk of future type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640
McKeigue, P. M., Shah, B., & Marmot, M. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)91164-p · Cited by 1,618
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508 · cited 2×
“Though the results of individual studies are sometimes conflicting (Eriksson et al., 1989; Martin et al., 1992; Robinson et al., 1992; Lillioja et al., 1993; Fernandez-Castaner et al., 1996; Holte, 1996; Perseghin et al., 1997; van Haeften et al., 1998), most have revealed defects in both insulin…”
BackgroundResultKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 1×
“The disposition index has the advantage of allowing β-cell function to be interpreted in the light of prevailing insulin resistance (Bergman et al., 1981; Kahn et al., 1993).”
BackgroundMartin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · cited 2×
“Though the results of individual studies are sometimes conflicting (Eriksson et al., 1989; Martin et al., 1992; Robinson et al., 1992; Lillioja et al., 1993; Fernandez-Castaner et al., 1996; Holte, 1996; Perseghin et al., 1997; van Haeften et al., 1998), most have revealed defects in both insulin action and secretion…”
ResultEarly Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widén, E., Schalin, C., & Groop, L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210601 · Cited by 807 · cited 2×
“Though the results of individual studies are sometimes conflicting (Eriksson et al., 1989; Martin et al., 1992; Robinson et al., 1992; Lillioja et al., 1993; Fernandez-Castaner et al., 1996; Holte, 1996; Perseghin et al., 1997; van Haeften et al., 1998), most have revealed defects in both insulin action and secretion…”
ResultBergman, R. N., Prager, R., Volund, A., & Olefsky, J. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112886 · Cited by 772 · cited 1×
“The insulin-modified, Bergman minimal modelling approach, used in our study, is a well-validated, commonly used, straightforward procedure, which has the advantage of evaluating simultaneously insulin sensitivity and secretion (Bergman et al., 1987; Yang et al., 1987; Saad et al., 1994).”
MethodHaffner, S. M., Ralph, D., Saad, M. F., Rewers, M., Mykkänen, L., Selby, J., Howard, G., Savage, P. J., Hamman, R. F., Wegenknecht, L. E., et al. (1996) · Diabetes · doi:10.2337/diab.45.6.742 · Cited by 536 · cited 1×
“Given that plasma concentrations of proinsulin and split proinsulin products are raised in type 2 diabetes and in prediabetic states (Temple et al., 1992; Hales et al., 1996), measurement of specific insulin has clear advantages.”
Background
Cited by
Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction
Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 259
Kousta, E., Efstathiadou, Z., Lawrence, N. J., Jeffs, J. A. R., Godsland, I. F., Barrett, S. C., Doré, C. J., Penny, A., Anyaoku, V., Millauer, B. A., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0058-6 · Cited by 74
Self-citationPrior gestational hyperglycemia: a long-term predictor of the metabolic syndrome
Bo, S., Monge, L., Macchetta, C., Menato, G., Pinach, S., Uberti, B., & Pagano, G. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347494 · Cited by 63
Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences
Kousta, E., Tolis, G., & Franks, S. (2005) · HORMONES · doi:10.14310/horm.2002.11151 · Cited by 35
Metadata
- Authors
- Kousta, E., Lawrence, N. J., Godsland, I. F., Penny, A., Anyaoku, V., Millauer, B. A., Cela, E., Johnston, D. G., Robinson, S., & McCarthy, M. I.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2003-08-14
- Volume
- 59
- Issue
- 3
- Pages
- 289-297
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2011668685
- Cited by
- 67
- References
- 18
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Insulin resistance and β‐cell dysfunction in normoglycaemic European women with a history of gestational diabetes. https://app.cochat.ai/papers/10.1046/j.1365-2265.2003.01820.x
- The paper
- Kousta, E., Lawrence, N. J., Godsland, I. F., Penny, A., Anyaoku, V., Millauer, B. A., Cela, E., Johnston, D. G., Robinson, S., & McCarthy, M. I. (2003). Insulin resistance and β‐cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2003.01820.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.